Get started
GERON CORP COM STK USD0.001GERON CORP COM STK USD0.001GERON CORP COM STK USD0.001

GERON CORP COM STK USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0IV3 chart


Full chart

Key facts today


Geron Corporation reported Q4 fiscal 2024 results on February 26, 2025, showing stagnant Rytelo growth. The stock dropped from $2.37 to $1.61, a decline of about 32%.
Analyze the impactAnalyze the impact

0IV3 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪808.88 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.27 USD
Net income (FY)
‪−174.57 M‬ USD
Revenue (FY)
‪76.99 M‬ USD
Shares float
‪597.84 M‬
Beta (1Y)
1.44

Employees


Employees (FY)
229
Change (1Y)
+88 +62.41%
Revenue / Employee (1Y)
‪336.22 K‬ USD
Net income / Employee (1Y)
‪−762.32 K‬ USD

About Geron Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Dawn Carter Bir
Website
geron.com
Headquarters
Foster City
Founded
1990
FIGI
BBG00JRQS0J0
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0IV3 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 0IV3.

Frequently Asked Questions


The current price of 0IV3 is 1.24 USD — it has increased by 3.02% in the past 24 hours. Watch GERON CORP COM STK USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange GERON CORP COM STK USD0.001 stocks are traded under the ticker 0IV3.
0IV3 stock has fallen by −7.84% compared to the previous week, the month change is a −28.20% fall, over the last year GERON CORP COM STK USD0.001 has showed a −66.76% decrease.
We've gathered analysts' opinions on GERON CORP COM STK USD0.001 future price: according to them, 0IV3 price has a max estimate of 7.00 USD and a min estimate of 2.00 USD. Watch 0IV3 chart and read a more detailed GERON CORP COM STK USD0.001 stock forecast: see what analysts think of GERON CORP COM STK USD0.001 and suggest that you do with its stocks.
0IV3 reached its all-time high on Mar 27, 2018 with the price of 5.98 USD, and its all-time low was 1.00 USD and was reached on Feb 4, 2022. View more price dynamics on 0IV3 chart.
See other stocks reaching their highest and lowest prices.
0IV3 stock is 3.02% volatile and has beta coefficient of 1.44. Track GERON CORP COM STK USD0.001 stock price on the chart and check out the list of the most volatile stocks — is GERON CORP COM STK USD0.001 there?
Today GERON CORP COM STK USD0.001 has the market capitalization of ‪808.88 M‬, it has decreased by −10.07% over the last week.
Yes, you can track GERON CORP COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
GERON CORP COM STK USD0.001 is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
0IV3 earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.025 USD resulting in a −62.53% surprise. The estimated earnings for the next quarter are −0.032 USD per share. See more details about GERON CORP COM STK USD0.001 earnings.
GERON CORP COM STK USD0.001 revenue for the last quarter amounts to ‪47.54 M‬ USD, despite the estimated figure of ‪61.84 M‬ USD. In the next quarter, revenue is expected to reach ‪50.46 M‬ USD.
0IV3 net income for the last quarter is ‪−25.35 M‬ USD, while the quarter before that showed ‪−26.45 M‬ USD of net income which accounts for 4.14% change. Track more GERON CORP COM STK USD0.001 financial stats to get the full picture.
No, 0IV3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 20, 2025, the company has 229 employees. See our rating of the largest employees — is GERON CORP COM STK USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GERON CORP COM STK USD0.001 EBITDA is ‪−172.51 M‬ USD, and current EBITDA margin is −224.06%. See more stats in GERON CORP COM STK USD0.001 financial statements.
Like other stocks, 0IV3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GERON CORP COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GERON CORP COM STK USD0.001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GERON CORP COM STK USD0.001 stock shows the sell signal. See more of GERON CORP COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.